Continuing the patent dispute internationally, China has now given the Charpentier/Doudna side a patent to edit genes in the country.
CRISPR pioneers Emmanuelle Charpentier and Jennifer Doudna lost a patent case to the Broad Insititute earlier this year when the court determined the Broad Insititute had an application markedly different than Charpentier’s and Doudna’s overall patent. Read More
Source: Tech Crunch